ICOSLG antibody (AA 19-258)
Quick Overview for ICOSLG antibody (AA 19-258) (ABIN3172719)
Target
See all ICOSLG AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 19-258
-
Cross-Reactivity
- Human
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu
-
Characteristics
- ICOS Ligand (CD275, Inducible T cell co-stimulator ligand, B7-H2, B7 homolog 2, B7-like protein Gl50, B7 related protein 1, B7H2, B7RP-1, B7RP1, GL50, ICOS LG , ICOSLG, KIAA0653, LICOS, Transmembrane protein B7 H2 ICOS ligand)
-
Purification
- Purified by Protein A affinity chromatography.
-
Endotoxin Level
- Endotoxin: <0.1EU/ug (LAL)
-
Immunogen
- Recombinant protein corresponding to Asp19-Ser258 from human ICOS Ligand expressed in NSO cells (O75144).
-
Isotype
- IgG2b
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute with 1 mL sterile PBS.
-
Buffer
- Supplied as a lyophilized powder from PBS, pH 7.4, 5 % trehalose.
-
Storage
- -20 °C
-
Storage Comment
- -20°C
-
-
- ICOSLG (Inducible T-Cell Co-Stimulator Ligand (ICOSLG))
-
Alternative Name
- ICOS Ligand
-
Pathways
- Production of Molecular Mediator of Immune Response, Activated T Cell Proliferation
Target
-